Stock Price Quote

SHARBON BIO

NSE : NABSE : 590034ISIN CODE : Industry : Pharmaceuticals & DrugsHouse : Private
BSE255.000 (0 %)
PREV CLOSE ( ) 255.00
OPEN PRICE ( ) 263.90
BID PRICE (QTY) 258.00 (25)
OFFER PRICE (QTY) 260.00 (58)
VOLUME 1120
TODAY'S LOW / HIGH ( )255.00 263.90
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year :
Management Info
- Chairman - Managing Director
Registered Office

Address W-34, 34/1, Midc Taloja,
Raigad,
Maharashtra-410208

Phone 9122- 27410490 55902070 55902071

Email --

Website  

Registrars Details
Link Intime India Pvt Ltd.
A-40, 2nd Floor,Naraina Industrial Area ,Phase II, Near Batra Banquet Hall,New Delhi
Listing : BSE

NEWS

09Dec Sharon Bio gets INVIMA Health Authorit
Sharon Bio-Medicine's Oral Solid Dosage facility at Dehradoon, Uttarakha..

Financials

in Millions
QTR Jun 07 ANNUAL 07
Net Profit57.52167.98
Gross Profit 73.54 227.43
Operating Profit 91.37263.54
Net Sales 645.731717.12

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE)
peergroup  2621.00 (5.75%)
M.Cap ( in Cr)1619.26
Glaxosmithkline Phar (BSE)
peergroup  2079.80 (7.06%)
M.Cap ( in Cr)35233.07
TTK Healthcare (BSE)
peergroup  1591.35 (5.77%)
M.Cap ( in Cr)2248.63
Cipla (BSE)
peergroup  1398.80 (3.79%)
M.Cap ( in Cr)112938.41
Torrent Pharma (BSE)
peergroup  2685.00 (1.85%)
M.Cap ( in Cr)90872.60

Shareholding Pattern

PROMOTERS 62.98%
FII 4.3%
NON-INSTITUTION 32.72%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%

About

no data found

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.